Table 5.6a

Immunosuppression Use for Induction, 1993 to 2002

Recipients with Kidney Transplants

	Year of Transplant
	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants	10,360	10,645	11,072	11,382	11,693	12,418	12,696	13,542	14,226	14,770
Tx With Immunosuppression Info	9,843	10,059	10,822	11,129	11,594	12,277	12,351	13,144	13,943	14,224
No Induction Drugs Recorded	88.8%	75.3%	73.3%	63.1%	65.7%	61.0%	52.7%	47.7%	42.3%	34.8%
Drugs	0.0%	0.0%	0.0%	0.0%	-	-	-	-	-	-
ALG
ATG	0.3%	0.4%	1.4%	14.2%	16.0%	11.0%	5.9%	3.2%	2.5%	2.0%
NRATG/NRATS	-	0.0%	0.1%	1.1%	1.3%	1.2%	0.7%	0.0%	-	-
OKT3	11.0%	24.3%	25.1%	21.5%	17.7%	10.0%	3.9%	1.8%	0.8%	1.0%
Thymoglobulin	-	-	-	-	0.0%	0.2%	4.9%	10.0%	17.1%	25.7%
Zenapax	-	0.0%	0.1%	0.2%	0.2%	13.1%	16.6%	13.2%	14.5%	13.2%
Simulect	0.0%	0.0%	0.2%	0.6%	0.1%	5.0%	17.3%	26.6%	25.4%	26.7%

Source: OPTN/SRTR Data as of August 1, 2003.

(-) = Drug not used anytime during the year.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.